Sutro Biopharma Inc (STRO)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Mr. Gregory K. ChowCFO | 2.50k | 0.00 | Derivative Exercise and Retained Stock | - | 4.73k | 112.36% |
| 2026-03-04 | Mr. David PaulingChief Administrative Officer & General Counsel | 398.00 | 0.00 | Derivative Exercise and Retained Stock | - | 9.75k | 4.26% |
| 2026-03-04 | Mr. David PaulingChief Administrative Officer & General Counsel | -277.00 | 5.90k | Derivative Exercise and Sale | 21.31 | 9.75k | - |
| 2026-03-04 | Ms. Jane ChungCEO & Director | 506.00 | 0.00 | Derivative Exercise and Retained Stock | - | 21.29k | 2.44% |
| 2026-03-04 | Ms. Jane ChungCEO & Director | -282.00 | 6.01k | Derivative Exercise and Sale | 21.31 | 21.29k | - |
| 2026-03-01 | Mr. David PaulingChief Administrative Officer & General Counsel | 2.18k | 0.00 | Derivative Exercise and Retained Stock | - | 9.35k | 30.35% |
| 2026-03-01 | Mr. David PaulingChief Administrative Officer & General Counsel | -1.52k | 31.21k | Derivative Exercise and Sale | 20.47 - 20.55 | 9.35k | - |
| 2026-03-01 | Dr. Hans-Peter GerberChief Scientific Officer | 2.34k | 0.00 | Derivative Exercise and Retained Stock | - | 9.52k | 32.51% |
| 2026-03-01 | Dr. Hans-Peter GerberChief Scientific Officer | -1.63k | 33.52k | Derivative Exercise and Sale | 20.47 - 20.55 | 9.52k | - |
| 2026-03-01 | Ms. Jane ChungCEO & Director | 6.89k | 0.00 | Derivative Exercise and Retained Stock | - | 20.78k | 49.59% |
| 2026-03-01 | Ms. Jane ChungCEO & Director | -4.05k | 83.13k | Derivative Exercise and Sale | 20.47 - 20.55 | 20.78k | - |
| 2025-12-12 | Ms. Jane ChungCEO & Director | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 13.89k | 13.07% |
| 2025-12-12 | Ms. Jane ChungCEO & Director | -894.00 | 7.17k | Derivative Exercise and Sale | 8.02 | 13.89k | - |
| 2025-10-15 | Dr. Hans-Peter GerberChief Scientific Officer | 1.70k | 13.61k | 買い | 8.00 | 7.18k | 31.00% |
| 2025-10-15 | Mr. Gregory K. ChowCFO | 1.98k | 16.00k | 買い | 8.10 | 1.98k | - |
| 2025-10-15 | Ms. Jane ChungCEO & Director | 1.25k | 10.01k | 買い | 8.01 | 12.29k | 11.33% |
| 2025-10-15 | Ms. Connie L. MatsuiIndependent Chair of the Board | 5.00k | 39.95k | 買い | 7.99 | 5.00k | - |
| 2025-10-15 | Mr. David PaulingChief Administrative Officer & General Counsel | 1.25k | 9.99k | 買い | 7.99 | 7.17k | 21.11% |
| 2025-09-18 | Dr. Hans-Peter GerberChief Scientific Officer | 2.41k | 0.00 | Derivative Exercise and Retained Stock | - | 5.48k | 78.33% |
| 2025-09-18 | Dr. Hans-Peter GerberChief Scientific Officer | -1.34k | 12.08k | Derivative Exercise and Sale | 9.00 | 5.48k | - |
| 2025-08-09 | Ms. Jane ChungCEO & Director | 1.20k | 0.00 | Derivative Exercise and Retained Stock | - | 11.04k | 12.25% |
| 2025-08-09 | Ms. Jane ChungCEO & Director | -670.80 | 5.37k | Derivative Exercise and Sale | 8.00 | 11.04k | - |
| 2025-07-08 | Dr. Barbara Leymanインサイダー | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 1.61k | - |
| 2025-07-08 | Dr. Barbara Leymanインサイダー | -894.40 | 6.98k | Derivative Exercise and Sale | 7.80 | 1.61k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。